Dld Asset Management, LP Immuno Gen, Inc. Put Options Transaction History

Dld Asset Management, LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 12, 2024	BUY	$12.46 - $29.95 $1.2 Million - $2.88 Million	96,000 New	96,000 $2.85 Million
Q2 2019 Aug 14, 2019	SELL	$1.8 - $3.3 $2.23 Million - $4.09 Million	-1,239,500 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$2.41 - $5.91 $2.99 Million - $7.33 Million	1,239,500 New	1,239,500 $3.35 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.